secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001104659-23-084289
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech CMO Dr. Margaret Marshall retires effective July 20, 2023; consulting agreement with continued equity vesting
--------------------------------------------------------------------------------

- Dr. Margaret Marshall retired as Chief Medical Officer of Vaccitech effective July 20, 2023.
- She will enter into a consulting agreement with the company for continued services.
- Certain of her equity interests will continue to vest for a nine-month period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465923084289/0001104659-23-084289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465923084289/tm2322054d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-084289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer